1. Home
  2. OCS vs HAFC Comparison

OCS vs HAFC Comparison

Compare OCS & HAFC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • OCS
  • HAFC
  • Stock Information
  • Founded
  • OCS 2003
  • HAFC 1982
  • Country
  • OCS Switzerland
  • HAFC United States
  • Employees
  • OCS N/A
  • HAFC N/A
  • Industry
  • OCS Biotechnology: Pharmaceutical Preparations
  • HAFC Major Banks
  • Sector
  • OCS Health Care
  • HAFC Finance
  • Exchange
  • OCS Nasdaq
  • HAFC Nasdaq
  • Market Cap
  • OCS 689.8M
  • HAFC 650.5M
  • IPO Year
  • OCS N/A
  • HAFC 1996
  • Fundamental
  • Price
  • OCS $19.45
  • HAFC $22.92
  • Analyst Decision
  • OCS Strong Buy
  • HAFC Buy
  • Analyst Count
  • OCS 4
  • HAFC 6
  • Target Price
  • OCS $31.50
  • HAFC $25.75
  • AVG Volume (30 Days)
  • OCS 29.0K
  • HAFC 116.9K
  • Earning Date
  • OCS 05-08-2025
  • HAFC 07-22-2025
  • Dividend Yield
  • OCS N/A
  • HAFC 4.72%
  • EPS Growth
  • OCS N/A
  • HAFC N/A
  • EPS
  • OCS N/A
  • HAFC 2.13
  • Revenue
  • OCS $847,333.00
  • HAFC $231,876,000.00
  • Revenue This Year
  • OCS $53.79
  • HAFC $17.80
  • Revenue Next Year
  • OCS $1,860.95
  • HAFC $7.22
  • P/E Ratio
  • OCS N/A
  • HAFC $10.76
  • Revenue Growth
  • OCS N/A
  • HAFC N/A
  • 52 Week Low
  • OCS $10.79
  • HAFC $14.97
  • 52 Week High
  • OCS $23.08
  • HAFC $27.59
  • Technical
  • Relative Strength Index (RSI)
  • OCS 58.76
  • HAFC 48.07
  • Support Level
  • OCS $17.33
  • HAFC $22.75
  • Resistance Level
  • OCS $20.45
  • HAFC $23.35
  • Average True Range (ATR)
  • OCS 0.80
  • HAFC 0.58
  • MACD
  • OCS 0.19
  • HAFC -0.13
  • Stochastic Oscillator
  • OCS 68.75
  • HAFC 40.60

About OCS Oculis Holding AG Ordinary shares

Oculis Holding AG is a global biopharmaceutical company purposefully driven to save sight and improve eye care. It includes OCS-01, a topical retinal candidate for diabetic macular edema (DME); OCS-02, a topical biologic candidate for dry eye disease (DED); and OCS-05, a disease modifying candidate for acute optic neuritis (AON) and other neuro-ophtha disorders such as glaucoma, diabetic retinopathy, geographic atrophy, and neurotrophic keratitis.

About HAFC Hanmi Financial Corporation

Hanmi Financial Corp is a Los Angeles-based bank that caters to Korean-Americans and other multi-ethnic communities across California, Colorado, Georgia, Illinois, New Jersey, New York, Texas, Virginia, and Washington. The bank mainly focuses on small businesses and commercial and real estate loans. Hanmi also offers trade-finance products. The bank has several lending offices outside California and plans to expand outside the state mainly through acquisitions. The Bank's revenues are derived from interest and fees on loans, interest, and dividends on the securities portfolio, service charges on deposit accounts, and sales of SBA loans.

Share on Social Networks: